You are here: Industry Insights > Cannabics

News List

Cannabics Pharmaceuticals and Purisys sign cannabinoid API supply agreement CPhIonline
November 08, 2021
Purisys has agreed to supply Cannabics Pharmaceuticals, a global developer of cancer-related cannabinoid-based medicine, with GMP-grade APIs required for the manufacturing of its colorectal cancer treatment drug candidate.
Cannabics Concludes Pre-Clinical Study on Human Biopsies americanpharmaceuticalreview
November 19, 2020
Cannabics Pharmaceuticals has completed a pre-clinical study using its proprietary and novel RCC-33 formulation on human biopsies, obtained under a Helsinki Committee approved protocol.
Cannabics Plans pre-IND Meeting Request for Colon Cancer Drug Candidate americanpharmaceuticalreview
October 28, 2020
Cannabics Pharmaceuticals has signed an agreement with a clinical quality and validation processes consultancy to oversee the preparation and submission of a Pre-IND Meeting request to the FDA on its anti-tumor Drug Candidate CANNABICS™ RCC-33 ...